Reliq Health is a digital health company that provides innovative SaaS solutions to the $100 billion Virtual Care market. Reliq's proprietary iUGO Care platform supports Remote Patient Monitoring, Telemedicine, Chronic Care Management, Transitional Care Management and Behavioral Health Integration. The company has over 50 clients in the US, Australia and Canada. Reliq expects to achieve cash flow positive in Q1 2021 and profitability in Q2 2021, with gross margins over 75% and EBITDA margins over 45%.
This telehealth company is expanding its platform to cover remote monitoring for pediatric patients with diabetes and other eligible conditions. Find out why one analyst says this company's stock is gathering momentum.
This telehealth company has signed a new contract with a Texas respiratory clinic that is expected to add 10,000 new patients to its iUGO platform by mid-2024. Read to see why one analyst believes this stock is a Buy.
Telehealth company Reliq Health Technologies signs five new contracts in four states for its iUGO platform, including its first contract in the state of Arkansas, where chronic diseases cost billions annually.
AlphaNorth Asset Management was recently recognized as the Number One equity hedge fund in Canada at the 2021 Alternative IQ Canadian Hedge Fund Awards due to its 5-year average investment return of 40.35%. Streetwise Reports sat down with the firm's co-Founder Steven Palmer to discuss some of the firm's recent investments and emerging opportunities for 2022.
Reliq Health Technologies signs contracts with three new clients for its proprietary remote healthcare delivery and care tracking platform, which has particularly significant implications during the era of the COVID-19 pandemic.read more >
Global telemedicine company will turn a profit in the current quarter and experience rapid growth after new contracts to provide chronic care management and medicare and medicaid reimbursements expand.read more >
Reliq Health Technologies reported the addition of four new skilled nursing facility customers in the southern U.S. and announced plans to expand its Care Management Team to meet the growing demand for Care Management Services.read more >
Reliq Health Technologies reported financial results for Q2/21 that demonstrated significant increases in quarterly revenues and gross margins; management expects to achieve profitability in the quarter ending June 30, 2021.read more >
Reliq Health Technologies reported it signed a new contract with a care management network for its iUGO Care platform to deliver customized healthcare to senior citizens in the Asian-American community throughout California.read more >
iDocsWeb reported it formed a strategic partnership with Reliq Health Technologies to offer that firm's iUGO Remote Patient Monitoring, Chronic Care Management and Behavioral Health solutions platforms to its U.S. customers.read more >
Reliq Health Technologies launched a multilingual interactive voice recognition product called iUGO Care IVR and has contracted with a Maryland physician practice to offer the service to patients speaking Russian and English.read more >
Reliq Health Technologies reported it has entered into a new contract with Diversified Healthcare Partners to provide its iUGO Care platform to more than 50,000 patients in three U.S. states.read more >
Reliq Health Technologies reported that it has signed contracts to add eight new customers in Texas including an oncology practice that will be using its new iUGO Care Principal Care Management module.read more >
A technology company that develops mobile health and telemedicine platforms for community-based healthcare has raised money, made a deal that will accelerate the number of patients it adds every month, and is breaking through its hardware logjam.read more >
StoneCastle Investment Management has a high-growth fund that invests wherever it finds opportunities, and it is bullish on healthcare. In this interview with The Life Sciences Report, portfolio manager Bruce Campbell highlights four companies that he is putting on Streetwise Reports' 2018 Biotech Watchlist.
read more >
As stock indexes in the U.S. hit record highs in 2017, we take a look at some of the best performers profiled by Streetwise Reports in the last year, some of which have seen triple digit increases.read more >
The rapid increase in the incidence of chronic diseases and the need to reduce healthcare costs have led to the growth in telemedicine, and Reliq Health Technologies is adding thousands of patients to its rolls.read more >
The rapid increase in the incidence of chronic diseases and the need to reduce healthcare costs have led to the growth in telemedicine, which has companies racing to bring new products to market.read more >
Source: Special to The Life Sciences Report (03/29/2016)
Moseda Technologies has developed innovative, secure mobile software solutions for the $20 billion community/home care market. In this interview, Moseda CEO Dr. Lisa Crossley describes the company's comprehensive hardware and software solution, dubbed CareKit, which allows patients to receive high-quality care in the home while reducing the cost of care.
read more >
SADIF Investment Analytics
"Reliq Health Technologies Inc. has a bright prospect. . .the company has fair financials and good earnings quality. . .the current market sentiment in relation to Reliq is positive with favorable technical indicators. . .we expect it to be a good long-term investment that is likely to deliver long-term returns."
SADIF Investment Analytics
"Reliq Health Technologies Inc.'s stock has been upgraded to Above Average from Average. . .the company has fair financials and good earnings quality. . .when compared to its closest competitor, Reliq shows greater undervaluation and is more likely to outperform the market."
"For Q1 FY23, valuation at Reliq Health Technologies Inc. suggests a lower amount of price risk. . .the company's balance sheet rating improved during the quarter on strengthening liquidity."
"The valuation for Reliq Health Technologies Inc. suggests a lower amount of price risk. . .a favorable valuation implies lower potential downward price risk that is evidenced by a company price multiple that is lower than the corresponding sector average. . .the balance sheet rating improved during Q1 FY23 on strengthening liquidity."
More Expert Comments
Clive Maund, CliveMaund.com
"Reliq Health Technologies Inc. still looks good here and in fact is at another Buy spot as it is starting to break out of a completing bull flag that has formed over the past couple of weeks. . .a breakout from the flag should lead to a rally of similar magnitude to the one preceding the flag. . .this is a good point to add to positions or make fresh purchases."
Douglas Loe, Leede Jones Gable
"Ontario-based Reliq Health Technologies Inc. is sustainably adding new clients for its iUGO Care platform in recent months, and just this morning added 50 new nursing home clients in Florida to its network, adding 5,000 patients per month (and so 60,000 patients per year) to its client base. . .the company will provide transitional care management to newly discharged patients at a rate of $60/month and remote health monitoring at a slightly higher rate of $65/month thereafter, at 75% gross margin."
Clive Maund, CliveMaund.com
"With the dip of recent days presenting us with a better entry point for Reliq Health Technologies Inc., this looks like a good time to buy. There is a clear line of support at CA$0.50, so a good point to place stops would be at about CA$0.485."
"Reliq Health Technologies Inc. is showing strong earnings quality and cash flow quality, and valuation suggests a lower amount of price risk. . .with a reported net income of -$800K in Q3/22 that was equal to the adjusted number, the company's quality of net income earnings is extremely high. In addition, operating cash flow increased during Q3/22 to -$1.5M from -$2.8M."
"Reliq Health Technologies Inc. is showing strong earnings quality and cash flow quality. . .with a reported net income of -$800,000 in Q3/22 that was equal to the adjusted number, the company's quality of net income earnings is extremely high. In addition, operating cash flow increased during Q3/22 to -$1.5M from -$2.8M."
Clive Maund, CliveMaund.com
"Reliq Health Technologies Inc. is rated an Immediate Buy here. It is down on support at the second low of what is believed to be [a] double bottom that formed following a quite heavy selloff."
9/27/2023 – Reliq Health Technologies, Inc. Announces New Contract with US Physician Network with over 300 Locations and over 750 Physicians Nationwide
9/12/2023 – Reliq Health Technologies, Inc. Announces New Contract with Leading US Healthcare Company with 75 Locations in Eight States
9/7/2023 – Reliq Health Technologies, Inc. Expands into Pediatric Remote Monitoring, Expects to Add 3,000 New Pediatric Patients in TX by Q2 2024
Reliq Health Technologies Inc. is a Billboard advertiser of Streetwise Reports and pays a flat fee. Fees fund both sponsor-specific activities and general report activities. Sponsor-specific activities may include aggregating content and publishing that content on the Streetwise Reports site, creating and maintaining company landing pages, interviewing key management, posting a banner/billboard, and/or issuing press releases.
The fees also cover the costs for Streetwise Reports to publish and syndicate investment opinion and comments, and also to curate or create sector-specific content.
Billboard advertising monthly fees range from $3,000 to $5,000.
This landing page contains a summary of the company that was prepared by that company.
Some landing pages contain investing highlights and a catalyst calendar that are prepared by that company.
The Expert Comments and Experts Following This Company sections of the landing page are compiled by Streetwise Reports.
There may be other information about the company that is not placed on the landing page, and Streetwise Reports does not guarantee the accuracy or thoroughness of the information contained on the landing page.
Readers should conduct their own research for all information publicly available concerning the company.
This landing page may be considered advertising for the purposes of 18 U.S.C. 1734.